ArticleDermatology and therapy2024

Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled Trials.

Joseph F Merola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.